• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

China stroke surveillance report 2021
AbstractSince 2015, stroke has become the leading cause of death and disability in China, posing a significant threat to the health of its citizens as a major chronic non-communicable disease. According to the China Stroke High-risk Population Screening and Intervention Program, an estimated 17.8 million [95% confidence interval (CI) 17.6 –18.0 million] adults in China had experienced a stroke in 2020, with 3.4 million (95% CI 3.3–3.5 million) experiencing their first-ever stroke and another 2.3 million (95% CI 2.2–2.4 million) dying as a result. Additionally, approximately 12.5% (95% CI 12.4–12.5%) of stroke survi...
Source: Military Medical Research - July 19, 2023 Category: International Medicine & Public Health Source Type: research

A Novel Atrial Fibrillation Evaluation Modelling Solution For NHS
Approximately every fifth stroke in UK is due to AF and costs the UK National Health Service are between $12,000 and $17,500 per stroke. The aim of this study was to undertake a retrospective health economic analysis of the cost-effectiveness and implications related to opportunistic Atrial Fibrillation (AF) screening in primary care and the detection of previously undiagnosed AF cases in patients, and create a novel modelling solution that can empower individual users and organisations in England, Wales and Northern Ireland in their decision making, technology assessment, comparison of various anticoagulation d rug group...
Source: Value in Health - October 1, 2017 Category: International Medicine & Public Health Authors: G Xydopoulos, R Fordham, Z Khanbai Source Type: research

Impact On Italian National Health Service Expenditure For The Treatment Of Venous Thromboembolism With Rivaroxaban
This study aims to evaluate the economic impact of the use of rivaroxaban for preventing DVT and PE in Italy.
Source: Value in Health - October 23, 2015 Category: Global & Universal Authors: A Roggeri, DP Roggeri, V Pengo Source Type: research

The Cost-Effectiveness Of Novel Oral Anticoagulants For The Prevention Of Stroke In Atrial Fibrillation In England And Wales
Determine the most cost-effective, licensed, first-line anticoagulant for the prevention of ischemic stroke in patients with non-valvular atrial fibrillation (AF) in England and Wales from the perspective of the UK National Health Service.
Source: Value in Health - October 23, 2015 Category: Global & Universal Authors: H Thom, W Hollingworth, PA Bryden, J Sterne, PN Bodalia, P Davies, JA Lopez-Lopez, GN Okoli, DM Caldwell, S Dias, D Eaton, J Higgins, C Salisbury, J Savovic, R Sofat, A Stephens-Boal, A Hingorani, NJ Welton Source Type: research

Costs And Outcomes Of Patients Admitted For A Cardiovascular Ischemic Disease In A Large Community Setting Of 2,989,512 Subjects Of The Italian National Health Service (Nhs)
To assess in a community setting the clinical characteristics, the outcomes and the related costs of patients admitted for an acute coronary syndrome (ACS) or a stroke/TIA (CVD) or a peripheral artery disease (PAD).
Source: Value in Health - May 1, 2015 Category: Global & Universal Authors: A.P. Maggioni, E. Cinconze, E. Rossi, M. De Rosa, I. Esposito, N. Martini Source Type: research